We narrowed to 10,290 results for: ada
-
Plasmid#135373PurposeExpression of nSaCas9 intradomain insertion of single evolved TadA monomer (V82G) at the specified position (E125 )DepositorInsertnSaCas9 E125 miniABEMax V82G
UseCRISPRExpressionMammalianMutation(V82G)Available SinceOct. 1, 2020AvailabilityAcademic Institutions and Nonprofits only -
nSaCas9 E131 miniABEMax V82G
Plasmid#135374PurposeExpression of nSaCas9 intradomain insertion of single evolved TadA monomer (V82G) at the specified position (E131 )DepositorInsertnSaCas9 E131 miniABEMax V82G
UseCRISPRExpressionMammalianMutation(V82G)Available SinceOct. 1, 2020AvailabilityAcademic Institutions and Nonprofits only -
nSaCas9 L132 miniABEMax V82G
Plasmid#135375PurposeExpression of nSaCas9 intradomain insertion of single evolved TadA monomer (V82G) at the specified position (L132 )DepositorInsertnSaCas9 L132 miniABEMax V82G
UseCRISPRExpressionMammalianMutation(V82G)Available SinceOct. 1, 2020AvailabilityAcademic Institutions and Nonprofits only -
nSaCas9 N130 miniABEMax V82G
Plasmid#135376PurposeExpression of nSaCas9 intradomain insertion of single evolved TadA monomer (V82G) at the specified position (N130 )DepositorInsertnSaCas9-ABEMax(V82G) N130
UseCRISPRExpressionMammalianMutation(V82G)Available SinceOct. 1, 2020AvailabilityAcademic Institutions and Nonprofits only -
nSaCas9 E735 miniABEMax V82G
Plasmid#135377PurposeExpression of nSaCas9 intradomain insertion of single evolved TadA monomer (V82G) at the specified position (E735 )DepositorInsertnSaCas9 E735 miniABEMax V82G
UseCRISPRExpressionMammalianMutation(V82G)Available SinceOct. 1, 2020AvailabilityAcademic Institutions and Nonprofits only -
nSaCas9 G129 miniABEMax V82G
Plasmid#135380PurposeExpression of nSaCas9 intradomain insertion of single evolved TadA monomer (V82G) at the specified position (G129 )DepositorInsertnSaCas9 G129 miniABEMax V82G
UseCRISPRExpressionMammalianMutation(V82G)Available SinceOct. 1, 2020AvailabilityAcademic Institutions and Nonprofits only -
nSaCas9 H119 miniABEMax V82G
Plasmid#135381PurposeExpression of nSaCas9 intradomain insertion of single evolved TadA monomer (V82G) at the specified position (H119 )DepositorInsertnSaCas9-ABEMax(V82G) H119
UseCRISPRExpressionMammalianMutation(V82G)Available SinceOct. 1, 2020AvailabilityAcademic Institutions and Nonprofits only -
nSaCas9 M732 miniABEMax V82G
Plasmid#135382PurposeExpression of nSaCas9 intradomain insertion of single evolved TadA monomer (V82G) at the specified position (M732 )DepositorInsertnSaCas9 M732 miniABEMax V82G
UseCRISPRExpressionMammalianMutation(V82G)Available SinceOct. 1, 2020AvailabilityAcademic Institutions and Nonprofits only -
nSaCas9 M741 miniABEMax V82G
Plasmid#135383PurposeExpression of nSaCas9 intradomain insertion of single evolved TadA monomer (V82G) at the specified position (M741 )DepositorInsertnSaCas9 M741 miniABEMax V82G
UseCRISPRExpressionMammalianMutation(V82G)Available SinceOct. 1, 2020AvailabilityAcademic Institutions and Nonprofits only -
nSaCas9 N120 miniABEMax V82G
Plasmid#135384PurposeExpression of nSaCas9 intradomain insertion of single evolved TadA monomer (V82G) at the specified position (N120 )DepositorInsertnSaCas9 N120 miniABEMax V82G
UseCRISPRExpressionMammalianMutation(V82G)Available SinceOct. 1, 2020AvailabilityAcademic Institutions and Nonprofits only -
S1 1029 miniABEMax V82G strategy1
Plasmid#135360PurposeExpression of circular permutant of nSpyCas9 at amino acid position 1029 encoding miniABEMax (evolved Tada monomer with V82G) at the N-terminusDepositorInsertmini ABEMax 1029 nSpyCas9
UseCRISPRExpressionMammalianMutation(V82G)Available SinceOct. 1, 2020AvailabilityAcademic Institutions and Nonprofits only -
S2 1058 V82G ABEMax
Plasmid#135361PurposeExpression of intradomain insertion of miniABEMax (evolved Tada monomer with V82G) at position 1058 of nSpyCas9DepositorInsert1058 nSpyCas9 V82G ABEMax
UseCRISPRExpressionMammalianMutation(V82G)Available SinceOct. 1, 2020AvailabilityAcademic Institutions and Nonprofits only -
S1 1029 V82G ABEMax Strategy 3
Plasmid#135363PurposeExpression of circular permutant of nSpyCas9 at amino acid position 1029 encoding miniABEMax (evolved Tada monomer with V82G) at the N-terminusDepositorInsert1029 V82G ABEMax
UseCRISPRExpressionMammalianMutation(V82G)Available SinceOct. 1, 2020AvailabilityAcademic Institutions and Nonprofits only -
pLenti-VRER-P2A-Puro
Plasmid#110849PurposeLentiviral vector for constitutive expression of Cas9-VRER (not codon optimized)DepositorInsertCas9-VRER
UseLentiviralTags3X FLAGMutationD1135V, G1218R, R1335E, T1337RPromoterEF1sAvailable SinceJune 27, 2018AvailabilityAcademic Institutions and Nonprofits only -
pLenti-HF1-P2A-Puro
Plasmid#110850PurposeLentiviral vector for constitutive expression of Cas9-HF1 (not codon optimized)DepositorInsertCas9-HF1
UseLentiviralTags3X FLAGMutationN497A, R661A, Q695A, Q926APromoterEF1sAvailable SinceJune 27, 2018AvailabilityAcademic Institutions and Nonprofits only -
pLenti-VQR-PGK-Puro
Plasmid#110855PurposeLentiviral vector for constitutive expression of Cas9-VQR (not codon optimized)DepositorInsertCas9-VQR
UseLentiviralTags3X FLAGMutationD1135V, R1335Q, T1337RPromoterEF1sAvailable SinceJune 27, 2018AvailabilityAcademic Institutions and Nonprofits only -
pLenti-VRER-PGK-Puro
Plasmid#110856PurposeLentiviral vector for constitutive expression of Cas9-VRER (not codon optimized)DepositorInsertCas9-VRER
UseLentiviralTags3X FLAGMutationD1135V, G1218R, R1335E, T1337RPromoterEF1sAvailable SinceJune 27, 2018AvailabilityAcademic Institutions and Nonprofits only -
pHH0103_FYB-1/2
Plasmid#91459PurposeProtein expression and purification of human SH3 domain construct FYB-1/2DepositorInsertFYB-1/2 (FYB1 Human)
ExpressionBacterialAvailable SinceMarch 19, 2018AvailabilityAcademic Institutions and Nonprofits only -
pHH0103_FYB-2/2
Plasmid#91300PurposeProtein expression and purification of human SH3 domain construct FYB-2/2DepositorInsertFYB-2/2 (FYB1 Human)
ExpressionBacterialAvailable SinceMarch 19, 2018AvailabilityAcademic Institutions and Nonprofits only -
pPN067
Plasmid#91602PurposeExpress sgRNA targeting human DPP4DepositorAvailable SinceOct. 12, 2017AvailabilityIndustry, Academic Institutions, and Nonprofits